Research Article
Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma
Table 1
Demographic data, coexistences, laboratory results, and imaging findings in HCC patients.
| | Variable | Total (N = 117) | μg/ml (N = 27) | μg/ml (N = 90) | value |
| | Age (years, ) | | | | 0.905 | | Gender (male/female) | 94/23 | 18/9 | 76/14 | 0.041 | | BMI (kg/m2, ) | | | | 0.468 | | Coexistences (, %) | | | | | | Smoking | 59 (50.4) | 13 (48.1) | 46 (51.1) | 0.787 | | Drinking | 40 (34.2) | 9 (33.3) | 31 (34.4) | 0.915 | | Hypertension | 24 (20.5) | 8 (29.6) | 16 (17.8) | 0.181 | | Diabetes mellitus | 10 (8.5) | 2 (7.4) | 8 (8.9) | 0.809 | | Virus hepatitis | 86 (73.5) | 13 (48.1) | 73 (81.1) | 0.001 | | Cirrhosis | 62 (53.0) | 12 (44.4) | 50 (55.6) | 0.310 | | Laboratory results ( or median, interquartile range) | | | | | | AFP (ng/ml) | 111.2 (4.7-106.8) | 11.2 (3.0-295.5) | 166.3 (5.3-2616.8) | 0.030 | | Leucocytes (×109/l) | | | | 0.477 | | Hemoglobin (g/l) | | | | 0.580 | | Platelet count (×109/l) | | | | 0.263 | | ALT (U/l) | 39.3 (22.5-62.9) | 38.0 (22.8-71.1) | 40.0 (22.1-60.1) | 0.313 | | AST (U/l) | 38.0 (25.3-58.3) | 37.9 (25.0-60.2) | 38.3 (25.8-58.4) | 0.779 | | ALP (U/l) | 101.8 (73.8-132.8) | 102.9 (71.0-124.0) | 102.0 (74.6-136.0) | 0.876 | | GGT (U/l) | 73.5 (41.6-136.8) | 66.0 (45.6-135.32) | 79.4 (39.2-140.5) | 0.954 | | TBIL (μmol/l) | | | | 0.932 | | DBIL (μmol/l) | | | | 0.422 | | ALB (g/l) | | | | 0.916 | | Cr (μmol/l) | | | | 0.093 | | BUN (mmol/l) | | | | 0.804 | | PT (s) | | | | 0.112 | | INR | | | | 0.063 | | Imaging findings ( or ) | | | | | | Tumor size (cm) | | | | 0.137 | | Single/multiple tumor | 94/23 | 21/6 | 73/17 | 0.702 | | TNM stage (I, II/III, IV) | 48/69 | 12/15 | 35/55 | 0.606 |
|
|
BMI: body mass index; AFP: alpha-fetoprotein; ALT: alanine transaminase; AST: aspartate transaminase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transpeptidase; TBIL: total bilirubin; DBIL: direct bilirubin; ALB: albumin; Cr: creatinine; BUN: blood urea nitrogen; PT: prothrombin time; INR: international normalized ratio.
|
